Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Leukemia|January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroupsDetlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic LeukemiaLuca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Blood Reviews|September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control studyMarie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Frontiers in Public Health|June 26, 2026
European Reference Networks as core health structures where referring genetic newborn screening positive infants: an innovative operational research frameworkFernanda Fortunato, Rita Selvatici, Jan Kirschner, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control studyAnne Laure Roupie, Alexis Guedon, Benjamin Terrier, et al.
Blood|March 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statementUma Borate, Kelly Pugh, Allyson Waller, et al.
Leukemia & Lymphoma|August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
Pageof 44